InvestorsHub Logo

sts66

11/25/19 3:40 PM

#230055 RE: KCSVEN #229939

Repatha and Praluent have had terrible sales because of the cost - if MDCO's drug isn't a fraction of the price of those other two it won't even sell $1.5B at the peak.